A randomized clinical trial of induction therapy with OKT3 in kidney transplantation.

Norman, D J; Kahana, L; Stuart, F P; Thistlethwaite, J R; Shield, C F; Monaco, A; Dehlinger, J; Wu, S C; Van Horn, A; Haverty, T P

Norman, D J; Kahana, L; Stuart, F P; Thistlethwaite, J R; Shield, C F; Monaco, A; Dehlinger, J; Wu, S C; Van Horn, A; Haverty, T P.

Affiliation

Norman DJ; Division of Nephrology, Oregon Health Sciences University, Portland 97201.

Transplantation ; 55(1): 44-50, 1993 Jan.

Article in En | MEDLINE | ID: mdl-8420063

Subject(s)

Graft Rejection/prevention & control; Graft Survival/drug effects; Kidney Transplantation/immunology; Muromonab-CD3/administration & dosage; Transplantation Immunology; Adolescent; Adult; Aged; Antibody Formation; Azathioprine/administration & dosage; Child; Cyclosporine/administration & dosage; Drug Administration Schedule; Female; Graft Rejection/immunology; Humans; Infections/epidemiology; Male; Methylprednisolone/administration & dosage; Middle Aged; Muromonab-CD3/adverse effects; Muromonab-CD3/immunology; Neoplasms/etiology; Prospective Studies; Succinates/administration & dosage; Succinic Acid; Time Factors; Transplantation Immunology/drug effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Transplantation Immunology / Kidney Transplantation / Muromonab-CD3 / Graft Rejection / Graft Survival Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Language: En Journal: Transplantation Year: 1993 Type: Article

Search on Google

XML

PubMed Links